Elsässer-Beile U - Search Results

1

Non-invasive in vivo imaging of tumor-associated CD133/prominin.

Tsurumi C, Esser N, Firat E, Gaedicke S, Follo M, Behe M, Elsässer-Beile U, Grosu AL, Graeser R, Niedermann G. Tsurumi C, et al. Among authors: elsasser beile u. PLoS One. 2010 Dec 20;5(12):e15605. doi: 10.1371/journal.pone.0015605. PLoS One. 2010. PMID: 21187924 Free PMC article.

2

Effective Eradication of Glioblastoma Stem Cells by Local Application of an AC133/CD133-Specific T-cell-Engaging Antibody and CD8 T Cells.

Prasad S, Gaedicke S, Machein M, Mittler G, Braun F, Hettich M, Firat E, Klingner K, Schüler J, Wider D, Wäsch RM, Herold-Mende C, Elsässer-Beile U, Niedermann G. Prasad S, et al. Among authors: elsasser beile u. Cancer Res. 2015 Jun 1;75(11):2166-76. doi: 10.1158/0008-5472.CAN-14-2415. Epub 2015 Apr 3. Cancer Res. 2015. PMID: 25840983

3

In vivo testing of 177Lu-labelled anti-PSMA antibody as a new radioimmunotherapeutic agent against prostate cancer.

Behe M, Alt K, Deininger F, Bühler P, Wetterauer U, Weber WA, Elsässer-Beile U, Wolf P. Behe M, et al. Among authors: elsasser beile u. In Vivo. 2011 Jan-Feb;25(1):55-9. In Vivo. 2011. PMID: 21282735

4

Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.

Fortmüller K, Alt K, Gierschner D, Wolf P, Baum V, Freudenberg N, Wetterauer U, Elsässer-Beile U, Bühler P. Fortmüller K, et al. Among authors: elsasser beile u. Prostate. 2011 May;71(6):588-96. doi: 10.1002/pros.21274. Epub 2010 Oct 13. Prostate. 2011. PMID: 20945402

5

Primary prostate cancer cultures are models for androgen-independent transit amplifying cells.

Bühler P, Wolf P, Katzenwadel A, Schultze-Seemann W, Wetterauer U, Freudenberg N, Elsässer-Beile U. Bühler P, et al. Oncol Rep. 2010 Feb;23(2):465-70. Oncol Rep. 2010. PMID: 20043108

6

A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells.

Bühler P, Wolf P, Gierschner D, Schaber I, Katzenwadel A, Schultze-Seemann W, Wetterauer U, Tacke M, Swamy M, Schamel WW, Elsässer-Beile U. Bühler P, et al. Cancer Immunol Immunother. 2008 Jan;57(1):43-52. doi: 10.1007/s00262-007-0348-6. Epub 2007 Jun 20. Cancer Immunol Immunother. 2008. PMID: 17579857 Free PMC article.

7

Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer.

Katzenwadel A, Schleer H, Gierschner D, Wetterauer U, Elsässer-Beile U. Katzenwadel A, et al. Anticancer Res. 2000 May-Jun;20(3A):1551-5. Anticancer Res. 2000. PMID: 10928069

8

PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.

Elsässer-Beile U, Reischl G, Wiehr S, Bühler P, Wolf P, Alt K, Shively J, Judenhofer MS, Machulla HJ, Pichler BJ. Elsässer-Beile U, et al. J Nucl Med. 2009 Apr;50(4):606-11. doi: 10.2967/jnumed.108.058487. Epub 2009 Mar 16. J Nucl Med. 2009. PMID: 19289418 Free article.

9

Targeting the prostate-specific membrane antigen for prostate cancer therapy.

Bühler P, Wolf P, Elsässer-Beile U. Bühler P, et al. Immunotherapy. 2009 May;1(3):471-81. doi: 10.2217/imt.09.17. Immunotherapy. 2009. PMID: 20635963 Review.

10

High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA.

Alt K, Wiehr S, Ehrlichmann W, Reischl G, Wolf P, Pichler BJ, Elsässer-Beile U, Bühler P. Alt K, et al. Among authors: elsasser beile u. Prostate. 2010 Sep 15;70(13):1413-21. doi: 10.1002/pros.21176. Prostate. 2010. PMID: 20687214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page